Presentation of Novakand Pharma’s Interim Report 2025 Q3 (In Swedish)
Kancera’s presentation at the Redeye Technology & Life Science Day 2024
Kancera presentation at the Redeye Theme: Cardiovascular & Metabolic Diseases Event 2024
Presentation of Kancera’s Interim Report for the first quarter 2024
Presentation of Kancera’s Interim Report for the fourth quarter 2023
Presentation of the statistical analyses of the FRACTAL top line results